<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383665</url>
  </required_header>
  <id_info>
    <org_study_id>HS-19-00518</org_study_id>
    <nct_id>NCT04383665</nct_id>
  </id_info>
  <brief_title>Low Frequency Subthalamic Nucleus Deep Brain Stimulation to Improve Verbal Fluency</brief_title>
  <official_title>Evaluation of Neurocognitive Changes in Parkinson's Disease Patients Following Acute Low Frequency Deep Brain Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Parkinson's disease patients with deep brain stimulation electrodes represent a
      unique opportunity to study the influence of basal ganglia on neurocognitive function.

      Intervention: Patients' deep brain stimulators will be turned off or on and the frequency
      will be changed to either theta or gamma.

      Objectives: To identify differences in higher cognitive functions with stimulation &quot;on&quot; and
      &quot;off&quot; and theta versus gamma frequency stimulation.

      Study population: 12 patients who had previously undergone bilateral STN deep brain
      stimulation implantation.

      Study methodology: Patients will undergo four sessions of neuropsychological testing (RNGT,
      verbal fluency, D-KEFS CWIT) at baseline, no stimulation, theta stimulation and gamma
      stimulation, in random order over one day.

      Study outcomes: Test results of RNGT, verbal fluency, D-KEFS CWIT. Follow-up: none

      Statistics: Test results will be analyzed using within-subjects statistical tests.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 31, 2020</start_date>
  <completion_date type="Actual">March 3, 2020</completion_date>
  <primary_completion_date type="Actual">March 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delis-Kaplan Executive Function System Verbal fluency</measure>
    <time_frame>5-15 minutes following stimulation frequency setting change.</time_frame>
    <description>Number of words per category in one minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delis-Kaplan Executive Function System Color Word Interference Task</measure>
    <time_frame>5-15 minutes following stimulation frequency setting change.</time_frame>
    <description>Time to completion of a color-word interference task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Random number generation</measure>
    <time_frame>5-15 minutes following stimulation frequency setting change.</time_frame>
    <description>Listing of 100 numbers at 1Hz in a random order</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>STN DBS off</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>STN DBS 10Hz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>STN DBS 130Hz</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STN DBS 10Hz</intervention_name>
    <description>Stimulation of existing DBS device at 100Hz, with other parameters at baseline</description>
    <arm_group_label>STN DBS 10Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STN DBS 130Hz</intervention_name>
    <description>Stimulation of existing DBS device at 130Hz, with other parameters at baseline</description>
    <arm_group_label>STN DBS 130Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STN DBS off</intervention_name>
    <description>Existing DBS device turned off</description>
    <arm_group_label>STN DBS off</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients who had previously undergone bilateral STN deep brain
             stimulation implantation

          2. Age &gt;18 years old

          3. Stable medication regimen for at least 3 months.

          4. Patient informed and able to give written consent

          5. Able to comply with all testing, follow-ups and study appointments and protocols

        Exclusion Criteria:

          1. History of epilepsy or seizure

          2. History of major substance abuse

          3. Patients with baseline settings at less than 1.5 V will be excluded from the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darrin J Lee, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Keck hospital of the University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Darrin J Lee, MD, PhD</investigator_full_name>
    <investigator_title>Assistant Professor of Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Cognition</keyword>
  <keyword>Hippocampus</keyword>
  <keyword>Language</keyword>
  <keyword>Memory</keyword>
  <keyword>Neuromodulation</keyword>
  <keyword>Randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

